Dr. Alrifai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 Luther Ln
Ste 2200
Park Ridge, IL 60068Phone+1 847-268-8200Fax+1 847-318-2905
Summary
- Dr. Taha Alrifai is a healthcare professional specializing in Internal Medicine with sub-specialties in Hematology and Oncology, based in Park Ridge, IL. He completed his fellowship in Hematology and Medical Oncology at Rush University Medical Center from 2020 to 2023 after finishing a residency and chief residency in Internal Medicine at Ascension Illinois/Saint Joseph (Chicago) from 2016 to 2020. His education began with the Damascus University Faculty of Medicine, where he graduated in 2014. Dr. Alrifai has contributed to medical research and knowledge through various publications in reputable journals such as The American Journal of Case Reports, Case Reports in Oncology, BMJ Case Reports, and Critical Care Explorations. His publications cover a range of topics, including post-transfusion purpura, myelofibrosis, adenocarcinoma metastasis, and autoimmune haemolytic anemia.
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2023
Ascension Illinois/Saint Joseph (Chicago)Chief Residency, Internal Medicine, 2019 - 2020- Ascension Illinois/Saint Joseph (Chicago)Residency, Internal Medicine, 2016 - 2019
Damascus University Faculty of MedicineClass of 2014
Certifications & Licensure
IL State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Uncommon Presentation of Post-Transfusion Purpura in an Elderly Male: A Case Report and Unique Alloantibody Identification.Laura Owczarzak, Taha Alrifai, Shivi Jain, Irene Dehghan-Paz
The American Journal of Case Reports. 2024-07-09 - 3 citationsTransfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Man with Heavily Pretreated Intermediate-2 Risk Primary Myelofibrosis.Nicole K Yun, Taha Alrifai, Ira J Miller, Jamile M Shammo
Case Reports in Oncology. 2022-02-14 - 5 citationsPembrolizumab-induced autoimmune haemolytic anemia in a patient with chronic lymphocytic leukaemia successfully treated with ibrutinib.Nicole K. Yun, Taha Alrifai, Ira Miller, Melissa L. Larson
BMJ Case Reports. 2021-09-21
Other Languages
- Arabic, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
